RC
BHC icon

RegentAtlantic Capital’s Bausch Health BHC Stock Holding History

RegentAtlantic Capital’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-635
Closed -$90.9K – 415
2014
Q4 		$90.9K Buy
+635
New +$85.4K 0.01% 472

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

RegentAtlantic Capital's BHC Position: Q1 2015 in Review

RegentAtlantic Capital sold out of Bausch Health (BHC) in Q1 2015, closing a stake of 635 shares — an estimated $90.9K sold.

RegentAtlantic Capital first reported a position in BHC in Q4 2014 and held it in 1 quarter. The position peaked at $90.9K in Q4 2014. 556 funds tracked by Wall St. Rank hold BHC as of Q1 2015.

  • RegentAtlantic Capital reported no remaining Bausch Health position as of Q1 2015 after selling out during the quarter.
  • RegentAtlantic Capital sold 635 Bausch Health shares in Q1 2015, an estimated $90.9K.
  • RegentAtlantic Capital first reported a position in Bausch Health in Q4 2014 and held it in 1 quarter.
  • RegentAtlantic Capital's Bausch Health position peaked at $90.9K in Q4 2014.
  • 556 funds tracked by Wall St. Rank held Bausch Health as of Q1 2015.

Based on RegentAtlantic Capital's 13F filing for Q1 2015, filed 27 Apr 2015.